Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep28 | Adrenal and Cardiovascular Endocrinology | ECE2023

Novel high resolution mass spectrometry profiling of free cortisol, cortisone, 6β- and 18-hydroxycortisol for the evaluation of glucocorticoid and mineralocorticoid disorders

Casals Gregori , Ballesteros Maria Antonieta , Zamora Angielys , Martinez Irene , Ruiz Montserrat , Fernandez-Varo Guillermo , Mora Mireia , Morales-Ruiz Manuel , Hanzu Felicia A

Introduction: Urine free cortisol measurements are routinely performed to evaluate hypercortisolism. Despite their analytical inaccuracy, immunoassay-based methods are frequently used. Advances in liquid chromatography high resolution mass spectrometry (LC-HRMS) facilitate the incorporation of powerful diagnostic tools into clinical laboratories with high analytical specificity that also allow simultaneous quantification of different metabolites and untargeted compound identif...

ea0090ep151 | Calcium and Bone | ECE2023

Evaluation of the efficacy and safety of long-term Cinacalcet in primary hyperparathyroidism

Huguet Isabel , Timon Iciar Martin , Moreno-Ruiz Inmaculada , Yannuzzi Vanessa Trivino , Llavero Maria , Meizoso-Pita Olalla , Gargallo Fernandez Manuel Angel , Sevillano-Collantes Cristina

Introduction: Cinacalcet is a positive allosteric modulator of the calcium sensing receptor successfully used to decrease serum calcium in primary hyperparathyroidism (pHPT) patients in the short-term, but long-term data are scarce. In this single-centre retrospective analysis, we investigated the efficacy and safety of cinacalcet in pHPT patients who received more than 5 years of treatment.Methods: Statistical analysis was performed using free online so...

ea0090ep674 | Pituitary and Neuroendocrinology | ECE2023

Tolvaptan in the management of severe hyponatremia associated with acute intermittent porphyria

Gomez Carlos Garcia , Armengod Laura , Abad Ainhoa , Garcia Izquierdo Belen , Guzman Sanz Jorge , Rubio Ramos Miguel , Capristan Diaz Vanesa , Diez Fernandez Natalia , Palacios Nuria

Background: Acute intermittent porphyria (AIP) is an inherited autosomal dominant disorder characterized by hepatic deficiency of hydroxymethylbilane synthase (HMBS)/porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Hyponatremia is one of the main presenting symptoms and it is thought to be related to an inadequate secretion of ADH (SIADH). Since AIP is an uncommon disease, there is little information about how AIP related hyponatremia responds ...

ea0090ep995 | Thyroid | ECE2023

Calcitonin Measurement in Needle Washout Fluid After Fine Needle Aspiration As a Complementary Diagnostic Test in Medullary Thyroid Carcinoma

Puzigaca Pavle , J Caballero Segura Manuel , Ignacio Fernandez Pena Jose , Arturo Cuellar Lloclla Eyvee , Bobillo Lobato Joaquin , Martinez de Pinillos Gordillo Guillermo

Introduction: The diagnostic accuracy of fine needle aspiration (FNA) in case of medullary thyroid cancer (MTC) has been less studied than in other thyroid cancers. The complementary measurement of calcitonin in the needle washout fluid after FNA (FNA-Ct) could improve the usefulness of this technique.Materials and Methods: Description of two cases of patients with thyroid nodules suspicious for MTC in whom FNA-Ct was measured as a complementary diagnost...

ea0090ep1111 | Late Breaking | ECE2023

Maternally inherited diabetes and deafness (MIDD): easy to detect?

Fernandez Garcia-Salazar Rosario , Manjon-Miguelez Laura , Costales Marcos Maria , Burgueno Montanes Carmen , Santirso Rodriguez Daniel , Garcia Gonzalez Noelia , Menendez Torre Edelmiro

Introduction: Maternally inherited diabetes and deafness (MIDD) that is caused by a pathogenic variant in mitochondrial DNA (mtDNA) can cause different phenotypes based on percent heteroplasmy load, with higher mutation load corresponding with disease severity. The m.A3243G mutation causes either classic MELAS or MIDD that is a partial form. The condition is characterised by diabetes, hearing impairment and maculopathy but can have several other clinical manifestations. Early ...

ea0065op6.1 | Neuroendocrinology, Pituitary and Neoplasia | SFEBES2019

Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease

Bashari Waiel A , Senanayake Russell , Fernandez-Pombo Antia , Gillett Daniel , Koulouri Olympia , Powlson Andrew , Cheow Heok , Mendichovszky Iosif , Kolias Angelos , Tysome James , Santarius Thomas , Mannion Richard , Gurnell Mark

Objective: To determine if an extended lateral approach to trans-sphenoidal surgery (TSS), guided by 11C-Methionine PET/CT co-registered with volumetric MRI (Met-PET/MRCR), can lead to remission in patients with persistent acromegaly due to post-operative lateral/para-sellar tumour remnants.Methods: We identified eight patients with persistent acromegaly following primary intervention [TSS ± medical therapy ± radiotherapy ...

ea0063gp183 | Benign Thyroid Disorders | ECE2019

High-dose intravenous levothyroxine treatment as a successful, safe and clinically effective therapy option in severe hypothyroidism: a retrospective study

Aznar Pablo Trincado , Garcia Maria Martinez , Sanchez Beatriz Lardies , Alaminos Maria Elena Lopez , Fernandez Mikel Gonzalez , Rosas Karol Almendra Alvarado , Lacleta Isabel Melchor , Perez Javier Acha

Introduction: Treatment of hypothyroidism with levothyroxine is effective and simple; however, international guidelines advise starting with low doses in case of severe hypothyroidism, cardiac illness and aged population. Interestingly, and in contradiction to this dogma, high doses of levothyroxine have been given to patients with myxedema coma without untoward effects. The difference between myxedema coma, which deserves an intensive treatment, and longstanding severe hypoth...

ea0063p184 | Diabetes, Obesity and Metabolism 1 | ECE2019

Diagnosis of type 1 DM in a patient with Hydroxymethylglutaric aciduria: Case report

Doulatram Gamgaram Viyey Kishore , Marin Montserrat Gonzalo , Molero Inmaculada Gonzalez , Fernandez Jose Abuin , Torralvo Francisco Jose Sanchez , Adana Marisol Ruiz de , Fuster Gabriel Olveira

Introduction: Hydroxymethylglutaric aciduria is a rare metabolic disease that is caused by the deficiency of the enzyme 3-hydroxy-3-methylglutaryl-CoA lyase, which participates in the metabolism of leucine and in the formation of ketone bodies. The symptomatology usually occurs in the first two years of life and consists of nausea, vomiting, diarrhea, hypotoniaanddepressed level of consciousness. Metabolic acidosis occurs during crises as a result of the accumulation of metabo...

ea0063p200 | Diabetes, Obesity and Metabolism 1 | ECE2019

PCSK9 inhibitors effects after 2 years in real life

Gonzalez Molero Inmaculada , Marin Montserrat Gonzalo , Gamgaram Viyey Kishore Doulatram , Fernandez Jose Abuin , Garcia Ignacio Ruiz , Herrera Maria Jose Vallejo , Fuster Gabriel Olveira

Introduction: Recently, PCSK9 inhibitors have been approved in our country for familial hypercholesterolemia and for patients with cardiovascular diseases. They are still scarce data in real life patients effects.Objective: Analyse the features of first patients treated with PCSK9 inhibitors in a specific unit of familial dyslipidemia and the effect on lipid profile and other clinical variables.Material and methods: Data from patie...

ea0063p269 | Pituitary and Neuroendocrinology 1 | ECE2019

Diabetes insipidus and diabetes mellitus type 2 diagnosed at the same time in a male with langerhans cell histiocytosis

Barcelo Carlos Antich , Soler Guillermo Serra , Font Mercedes Noval , Ribas Elena Mena , Povidano Santiago Tofe , Jimenez Inaki Arguelles , Fernandez Honorato Garcia , Macazaga Vicente Pereg

Introduction: Langerhans cell histiocytosis (LCH) is a rare systemic disease. Diabetes insipidus is the most frequent endocrine alteration and occurs mostly after diagnosis. Others are hypogonadism, growth hormone deficiency (GHD) and alterations in glucose metabolism.Clinical case: A 61-year-old smoker, diagnosed with LCH 9 years ago with pulmonary and hepatic involvement, without treatment, who consulted for asthenia, unquantifiable polyuria, polydipsi...